All Press Releases for October 13, 2023

Dr. Spiros Garbis Celebrated for Dedication to the Field of Biotechnology

Spiros Garbis, PhD lends years of expertise to his work with Proteas Bioanalytics

Dr. Garbis aims to have his company's patented technology validated and available resources to HMOs and industrial settings.

    GLENDALE, CA, October 13, 2023 /24-7PressRelease/ -- Spiros Garbis has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Drawing on years of professional expertise, Dr. Garbis presently excels the founder, president, chief technology officer, and chief executive officer of Proteas Bioanalytics Inc., a healthcare biotechnology company that develops advanced platforms for the analysis of clinical specimens. The company specializes in analyzing blood specimens for the early diagnosis of diseases with precision medicine guidance. In this capacity, he refines platform and compound designs, and oversees technology implementation across various experimental protocols and research engagements. Alongside his work with Proteas, Dr. Garbis is a visiting professor at the University of Southampton, from his previous post as an associate professor for this institution. Dr. Garbis also serves as an instructor for the Precision Proteomics Module of the Kaiser Permanente School of Medicine at Pasadena, California.

Over the years, Dr. Garbis honed his expertise in research, education, and chemistry as the Director of the Proteome Exploration Laboratory and principal investigator at Caltech, Division of Biology and Biological Engineering, as a Faculty member and investigator at the Biomedical Research Foundation at the Academy of Athens, a research associate at the University of Illinois at Chicago, and an analytical chemist for NOW Foods, Inc.'s quality control and quality assurance department. During the early stages of his career, he gained valuable expertise in the field with the University of Illinois where he conducted fundamental and applied mass spectrometry studies for the analysis of biological materials and Zellweger Analytics where he helped develop remote sensitive infrared spectroscopy technologies for the monitoring of gaseous pollutants in open atmospheres. Due to his outstanding breadth of knowledge, Dr. Garbis obtained a patent for mass spectrometry sample processing methods, chromatography devices, and data analysis techniques for biomarker analysis.

An expert in his field, Dr. Garbis earned a Bachelor of Science in Chemistry (certified by the American Chemical Society) from the University of Illinois, Chicago. He earned his PhD in Pharmacology, Molecular and Biochemical Toxicology track from the University of Illinois at Chicago's Graduate College. Driven to remain abreast of changes in the field, Dr. Garbis aligns himself with the American Society for Mass Spectrometry and the American Chemical Society.

Outside of his work, Dr. Garbis contributes to those less fortunate as a member of the executive leadership team at the Leukemia & Lymphoma Society. While his career has been filled with highlights, he takes the most pride in developing a breakthrough blood-testing technology that can detect diseases at an early stage. The cornerstone of his success lies with his colleagues and graduate and postgraduate students, as well as his co-founder and chief scientific officer, Dr. Antigoni Manousopoulou. In the coming years, Dr. Garbis aims to have his company's patented technology validated and available resources to HMOs and industrial settings. Additionally, he would like to contribute to environmental causes by promoting good nutrition, biodiversity, and food security.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: